GK

Ganesh Kaundinya

President and CEO

GlycoEra AG

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
GlycoEra AG
Industry
research
Employees
35.0
Seniority
C suite
Annual Revenue
1700000.0
Total Funding
49000000.0
Latest Funding
Series A

Technologies

Mimecast Outlook Microsoft Office 365 GoDaddy Hosting Google Font API Varnish Mobile Friendly WordPress.org

Keywords

glycoengineering therapeutic product development biopharmaceutical cmc development biotechnology research precision immunology biologics autoimmune diseases therapeutic index protein degradation circulating proteins disease-causing proteins early intervention patient outcomes quality of life bifunctional biologics extracellular protein immunosuppressive therapies deep degradation specific targeting monoclonal antibodies selective degradation safety profile patient-centered clinical effectiveness biotech immuno-oncology removal of off-target effects treatment paradigm reproducible platform novel therapeutics target protein therapeutic areas protein aggregates disease targets fast track therapies advanced treatments healthcare costs sustainable solutions research & development disease intervention drug discovery therapeutic strategies biopharmaceuticals cancer therapies novel expression system glycan engineering health outcomes collaborative approach market access

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans